Tuesday, November 26, 2024
HomeTagsInxMed FAK Inhibitor

InxMed FAK Inhibitor

InxMed FAK Inhibitor IN10018 Received Breakthrough Therapy Designation by the China National Medical Products Administration for Platinum-Resistant Ovarian Cancer

InxMed Co., Ltd. announced that IN10018, its focal adhesion kinase (FAK) inhibitor, had been granted with Breakthrough Therapy Designation by the China National Medical...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics